Maravai LifeSciences Holdings, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
Maravai LifeSciences Holdings, Inc. (MRVI) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $375.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-08-07
- 2026-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $375.00K.
- 2026-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $4.08M.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.36M.
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.72M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $375.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.08M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $1.36M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.72M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $4.08M 10-Q · filed 2025-05-12 |
| 2024-09-30 | $1.36M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.72M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.08M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $1.36M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.72M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.08M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $1.36M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $2.72M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $4.08M 10-Q · filed 2022-05-06 |
| 2021-09-30 | $1.50M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.00M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $4.50M 10-Q · filed 2021-05-12 |